- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02885935
Dairy Macronutrient Effects on the Metabolic Syndrome
August 26, 2016 updated by: University of Arkansas
The investigators examined the effects of 4-week dietary protein intake in mixed meals at two levels of protein amount on whole body glucose metabolisms in older adults with metabolic syndrome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators investigated changes in insulin sensitivity before and after 4 weeks of dietary intervention and control in subjects with metabolic syndrome.
Two groups of subjects were studied before and after a weight maintenance diet.
Group 1 was fed a common American diet with a macronutrient distribution of 10% protein, 55% carbohydrates, and 35% fat.
Group 2 consumed a higher protein diet (20%; 1.4 g/kg/d of protein).
Carbohydrate intake was lower in Group 2 (45%), with fat intake (largely derived from dairy sources) similar between groups.
Glucose utilization and endogenous glucose production were determined during an oral glucose tolerance test (OGTT) with a novel double-tracer approach.
The secondary aim was to determine the effect of a diet high in dairy consumption on blood lipid profiles.
The investigators measured blood lipids before and after dietary intervention in each group.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women, ages 45-75 years AND
- BMI greater than 30 kg/m2 AND
Two of the following conditions:
- Plasma triglycerides > 130 mg/dl
- HDL < 40 mg/dl in men or 50 mg/dl in women
- elevated screening blood pressure (systolic > 140 or diastolic >90 mm Hg) or taking medication for hypertension
- fasting plasma glucose > 100mg/dl
Exclusion Criteria:
- Hemoglobin A1c > 7.5
- History of malignancy in the 6 months prior to enrollment
- History of lactose intolerance or dairy allergy
- History of gastrointestinal bypass surgery (Lapband, etc)
- History of a chronic inflammatory condition or disease (Lupus, HIV/AIDS, etc)
- Subjects who do not or will not eat animal proteins
- Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study
- Subjects who use insulin to control their blood sugar
- Subjects whose physician will not allow suspension of oral diabetes medications for the duration of the study (~5 weeks)
- Concomitant use of corticosteroids (ingestion, injection or transdermal)
- Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Recommended protein intake
Subjects consumed diets with a macronutrient distribution of 10% protein, 55% carbohydrates, and 35% fat for 4 weeks.
|
Recommended protein intake diet contained 10% protein, 55% carbohydrate,and 35 % fat.
|
|
EXPERIMENTAL: Elevated protein intake
Subjects consumed diets with a macronutrient distribution of 20% protein, 45% carbohydrates and 35% fat for 4 weeks.
|
Recommended protein intake diet contained 20% protein, 45% carbohydrate,and 35 % fat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in rate of glucose disappearance
Time Frame: Change from baseline and after 4weeks of dietary intervention
|
Rate of glucose disappearance from plasma to body tissues is a measure of whole body insulin sensitivity
|
Change from baseline and after 4weeks of dietary intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
September 1, 2014
Study Registration Dates
First Submitted
August 24, 2016
First Submitted That Met QC Criteria
August 26, 2016
First Posted (ESTIMATE)
September 1, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
September 1, 2016
Last Update Submitted That Met QC Criteria
August 26, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 138447
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
Clinical Trials on Recommended protein intake
-
University of ArkansasCompletedSarcopeniaUnited States
-
USDA Grand Forks Human Nutrition Research CenterUniversity at Buffalo; USDA, Western Human Nutrition Research CenterCompleted
-
University Medical Centre LjubljanaCompletedAdolescent | Children | Hydration | Primary Headaches (Includes Migraines, Tension, Cluster Headaches)Slovenia
-
Maastricht University Medical CenterNot yet recruitingNo Condition, Healthy IndividualsNetherlands
-
University of Sao PauloUnknownCancer | Surgery | Critically IllBrazil
-
University of ArkansasCompleted
-
Kaiser PermanenteCompletedMalnutrition | Hypoalbuminemia | Peritoneal Dialysis ComplicationUnited States
-
The Hospital for Sick ChildrenCompleted
-
The Hospital for Sick ChildrenCompletedHealthy Males 65-75 Yrs OldCanada